• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Who's Who In Cannabis: Latest Executive Changes You Should Know About

    4/15/24 8:22:56 PM ET
    $CMPS
    $DB
    $IGC
    $TPB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Banks
    Finance
    Get the next $CMPS alert in real time by email

    As the Benzinga Cannabis Capital Conference gets underway in Florida, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes in space, starting with companies that named new CEOs over the past period.

    Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) tapped Benjamin Sze to serve as its CEO a week ago, succeeding Paul Wilson. Sze rejoined the company after previously serving as CEO before resigning in late 2020 to focus on his family.

    Denver-based Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX:SHWZ) (NEO: SHWZ)  appointed its CFO Forrest Hoffmaster to the additional role of interim CEO in late February, following Nirup Krishnamurthy’s resignation as CEO and as a member of the board of directors.

    Cannabis packaging and logistics company DIZPOT named Laura Sidney as its interim CEO in March.

    Online cannabis seed bank I Love Growing Marijuana, wrapped up last month by welcoming Ernst Rustenhoven as its new CEO.

    Interestingly, chief executive officers leading U.S.-based multi-state cannabis operators have surpassed the $500,000 base salary threshold in 2024 with annual median salaries topping $511,600 and representing a nearly 8% year-over-year increase. That’s roughly seven times what mid-level managers in the industry make, according to CannabizTeam Worldwide‘s 2024 Cannabis Industry Salary Guide.

    See also: International Cannabis Executives To Watch In 2024

    Multiple Appointments

    • District Cannabis, the premier cannabis cultivator in Maryland and the District of Columbia appointed Bethany Frick as CEO and Bryce Freeman as COO recently, in an attempt to "position the company well as it forges ahead with its market expansion efforts in the region."
    • Cannabis company Jones Soda Co. (CSE:JSDA) (OTCQB:JSDA), behind the original craft soda, recently announced a new operations team in March. Beverage expert Eric Bittner joined Jones as its new chief operating officer while experienced research and development scientist Mary Money has been named director of new product development and commercialization.
    • ElleVet Sciences, a maker of hemp-based CBD products for pets recently expanded its executive leadership team with the promotion of Haley Israelson to chief financial officer and the addition of Ryan Shadrin as chief commercial officer.

    New COOs and CFOs

    • On Monday, vertically integrated, multi-state cannabis operator Jushi Holdings Inc. (CSE:JUSH) (OTCQX:JUSHF) appointed Todd West as its head of operations.
    • Cannabis genetics company Phylos, advancing the science of cannabis and making large-scale cannabis production profitable and environmentally sustainable, named Whitney Conroy as its chief commercial officer in February.
    • Cannabis consumer products maker and distributor Turning Point Brands, Inc. (NYSE:TPB) named Andrew Flynn as the head of its finance department in March.
    • Greenway Greenhouse Cannabis Corporation (CSE:GWAY) (OTCQB:GWAYF), a cultivator of high-quality greenhouse cannabis for the Canadian market, also named a new chief finance officer recently, Kyle Appleby who has "an impressive track record of financial leadership spanning over two decades."

    Latest Board Changes

    • Vancouver-based developer of marijuana and alcohol breath testing devices Cannabix Technologies Inc. (CSE:BLO) (OTC:BLOZF) kicked off April by welcoming Dr. Phillip Olla (Ph.D.) to its board of directors.
    • In March, healthcare expert Terry Lierman joined IGC Pharma, Inc. (NYSE:IGC) as an independent director of the board to advance the company's Alzheimer's pipeline.
    • iAnthus Capital Holdings, Inc. (CSE:IAN) (OTCQB:ITHUF) announces the resignation of John Paterson from its board of directors in mid-March.
    • Meanwhile, Simply Solventless Concentrates Ltd. (TSXV:HASH) tapped veteran cannabis executive Olen Vanderleeden to serve on its board of directors in February.
    • In late March, Compass Pathways plc (NASDAQ:CMPS) announced its co-founders, George Goldsmith and Ekaterina Malievskaia, resigned from the company's board of directors.

    Other Industry Appointments, Resignations And Promotions

    • Cannabis Bioscience International Holdings (OTC:CBIH) reported in February that Brian Cuban, the younger brother of the former principal owner of the Dallas Mavericks, Mark Cuban, has been elected to serve as an advisory board member in the firm.
    • Massachusetts-based Needham Bank expanded its cannabis banking practice and has hired Brandon Curran as vice president and business development officer to help build market share.
    • On Thursday, Shield Compliance, a compliance platform for cannabis banking, said it has promoted Jenna Meyer to the position of chief operating officer and Cami Cantrell to executive vice president of administration and professional services.
    • Alabama Medical Cannabis Commission's (AMCC) member Dr. Jerzy Szaflarski resigned in April. An M.D. and Ph.D. with the UAB School of Medicine, Szaflarski was appointed to the AMCC in September 2021, as reported by 1819 News.
    • Meanwhile, Grasslands: A Journalism-Minded Agency, a cannabis and psychedelics PR and marketing, recently officially expanded into the broader natural products and wellness sector.

    Now read: Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024

    The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

    Get your tickets now on bzcannabis.com – Prices will increase very soon!

    Get the next $CMPS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMPS
    $DB
    $IGC
    $TPB

    CompanyDatePrice TargetRatingAnalyst
    COMPASS Pathways Plc
    $CMPS
    12/10/2025$15.00Perform → Outperform
    Oppenheimer
    Deutsche Bank AG
    $DB
    8/27/2025Buy → Neutral
    Goldman
    Turning Point Brands Inc.
    $TPB
    8/1/2025Hold
    Needham
    Deutsche Bank AG
    $DB
    7/25/2025Neutral → Sell
    Citigroup
    COMPASS Pathways Plc
    $CMPS
    6/23/2025$11.00 → $6.00Outperform → In-line
    Evercore ISI
    Deutsche Bank AG
    $DB
    6/10/2025Buy
    BofA Securities
    Turning Point Brands Inc.
    $TPB
    3/3/2025$80.00Buy
    Alliance Global Partners
    COMPASS Pathways Plc
    $CMPS
    2/27/2025$11.00Buy
    Stifel
    More analyst ratings

    $CMPS
    $DB
    $IGC
    $TPB
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Turning Point Brands Inc.

    SCHEDULE 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    2/12/26 11:15:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    SEC Form F-N filed by Deutsche Bank AG

    F-N - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Subject)

    2/10/26 3:43:44 PM ET
    $DB
    Major Banks
    Finance

    SEC Form S-8 filed by Deutsche Bank AG

    S-8 - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Filer)

    2/10/26 3:02:35 PM ET
    $DB
    Major Banks
    Finance

    $CMPS
    $DB
    $IGC
    $TPB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    COMPASS Pathways upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded COMPASS Pathways from Perform to Outperform and set a new price target of $15.00

    12/10/25 8:10:44 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deutsche Bank downgraded by Goldman

    Goldman downgraded Deutsche Bank from Buy to Neutral

    8/27/25 8:18:54 AM ET
    $DB
    Major Banks
    Finance

    Needham initiated coverage on Turning Point Brands

    Needham initiated coverage of Turning Point Brands with a rating of Hold

    8/1/25 8:13:43 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $CMPS
    $DB
    $IGC
    $TPB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moran James P bought $200,000 worth of shares (588,235 units at $0.34) (SEC Form 4)

    4 - IGC Pharma, Inc. (0001326205) (Issuer)

    9/27/24 4:05:18 PM ET
    $IGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares (4,000 units at $31.80), increasing direct ownership by 13% to 34,896 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/24 5:01:10 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Chief Revenue Officer Frein Summer bought $69,970 worth of shares (2,260 units at $30.96), increasing direct ownership by 15% to 17,203 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/14/24 6:50:56 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $CMPS
    $DB
    $IGC
    $TPB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stoker's Introduces Stoker's Proud: A New Value Driven Dip Built on American Craftsmanship

    LOUISVILLE, KY, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Stoker's, a category leader in 100% American-made smokeless tobacco for more than 85 years, announced the launch of Stoker's Proud®, a new sub-brand designed to meet growing consumer demand for high-quality, affordable tobacco products—without compromising the standards that define the Stoker's name. As value-focused segments continue to grow, driven by consumers seeking more accessible price options, Stoker's Proud offers a smart extension of the Stoker's portfolio. The new sub-brand delivers the same commitment to quality and consistency Stoker's is known for, while providing a distinct product experience and price point that compleme

    2/16/26 11:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

    Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will report new clinical data from two ongoing Phase 3 trials evaluating COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). The company will be disclosing new clinical data from Part A and Part B from COMP005 and Part A from COMP006. The results are scheduled for release on February 17th at 6:30 am ET, followed by a webinar hosted by Compass management at 8:00 am ET. Live Webcast Compass management will host a live audio webcast on February 17th at 8:00 am ET. The webcast will be

    2/16/26 8:00:00 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deutsche Bank appointed as Successor Depositary Bank for the American Depositary Receipt Program of Swisscom AG

    Deutsche Bank announced today its appointment as successor depositary bank for the sponsored American Depositary Receipt program of Swisscom AG. Swisscom AG (OTC:SCMWY) is a leading information and communications technology company in Switzerland and Italy. Swisscom offers mobile, internet and TV, as well as comprehensive IT and digital services to private and business customers. Swisscom is 51% owned by the Swiss Confederation, employs nearly 20,000 people and is headquartered in Ittigen, Switzerland.* In addition to specializing in administering cross-border equity structures such as New York Shares and American and Global Depositary Receipts, Deutsche Bank provides corporates, financ

    1/30/26 1:54:00 PM ET
    $DB
    Major Banks
    Finance

    $CMPS
    $DB
    $IGC
    $TPB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Mukunda Ram converted options into 50,000 shares (SEC Form 4)

    4 - IGC Pharma, Inc. (0001326205) (Issuer)

    2/4/26 5:31:07 PM ET
    $IGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nath Kabir covered exercise/tax liability with 16,181 units of Ordinary Shares, decreasing direct ownership by 7% to 205,121 units (SEC Form 4)

    4 - COMPASS Pathways plc (0001816590) (Issuer)

    2/3/26 5:19:56 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Prins Richard K converted options into 100,000 shares, increasing direct ownership by 8% to 1,371,251 units (SEC Form 4)

    4 - IGC Pharma, Inc. (0001326205) (Issuer)

    1/20/26 4:01:43 PM ET
    $IGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPS
    $DB
    $IGC
    $TPB
    Leadership Updates

    Live Leadership Updates

    View All

    Webull Appoints Walter Bishop to Board of Directors

    Mr. Bishop to serve as Independent Director and member of the Audit, Compensation and Nominating and Corporate Governance Committees ST. PETERSBURG, Fla., June 9, 2025 /PRNewswire/ --  Webull Corporation (NASDAQ:BULL) ("Webull" or the "Company"), the owner of the Webull online investment platform, today announced the appointment of Walter Bishop as independent director to its Board of Directors, effective June 8, 2025. Mr. Bishop will serve as a member of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Mr. Bishop brings extensive

    6/9/25 8:45:00 AM ET
    $BULL
    $DB
    $INDI
    Investment Bankers/Brokers/Service
    Finance
    Major Banks
    Semiconductors

    Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

    Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into a strategic collaboration with HealthPort, a multi-site comprehensive community health organization. HealthPort employs an integrated model centered around social determinants of health and this collaboration will help inform the potential delivery of COMP360 synthesized psilocybin treatment in underserved communities, if FDA approved. This agreement with HealthPort expands the set of collaborations that Compass has established representing a broad spectrum of settings where people living with treatment resistant depression (TR

    4/29/25 6:30:00 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor

    POTOMAC, MD / ACCESS Newswire / January 21, 2025 / IGC Pharma, Inc. (NYSE:IGC) ("IGC Pharma" or the "Company") is pleased to announce the appointment of Terry McAuliffe, the 72nd Governor of Virginia, as a strategic advisor. Governor McAuliffe's extensive leadership experience across public and private sectors will play a pivotal role in advancing IGC Pharma's mission to redefine Alzheimer's care and position the Company for growth in the biotechnology and pharmaceutical industries. As strategic advisor, Governor McAuliffe will focus on refining IGC Pharma's growth strategies, driving business development initiatives, and fostering partnerships with leading pharmaceutical and healthcare o

    1/21/25 8:30:00 AM ET
    $IGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPS
    $DB
    $IGC
    $TPB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by COMPASS Pathways Plc

    SC 13G/A - COMPASS Pathways plc (0001816590) (Subject)

    11/14/24 4:35:16 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by COMPASS Pathways Plc

    SC 13G/A - COMPASS Pathways plc (0001816590) (Subject)

    11/14/24 4:20:24 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/14/24 12:37:11 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $CMPS
    $DB
    $IGC
    $TPB
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Turning Point Brands Inc. on Jun 18 Indicate?

    On June 18, 2024, Turning Point Brands Inc. experienced a significant insider purchase when Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares. This transaction involved the acquisition of 4,000 units at a price of $31.80 per unit, leading to an increase in his direct ownership by 13% to 34,896 units, as reported in the SEC Form 4. This move by an insider to increase their stake in the company is generally viewed as a positive signal by the market. Examining the recent insider activity at Turning Point Brands Inc., we can identify a few notable trades that occurred around the same time. On May 10, 2024, New insider Catsimatidis John A. Jr claimed ownership of 410,000 sh

    6/18/24 10:08:05 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $CMPS
    $DB
    $IGC
    $TPB
    Financials

    Live finance-specific insights

    View All

    Turning Point Brands Announces Third Quarter 2025 Results

    Consolidated Net Sales for Q3 2025 increased 31.2% year-over-year to $119.0 million Modern Oral Net Sales for Q3 2025 increased 627.6% year-over-year to $36.7 million, accounting for 30.8% of total Company Net Sales Q3 2025 Adjusted EBITDA of $31.3 million, up 17.2% over prior year Company increasing 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) Company increasing full-year Modern Oral sales guidance to $125.0 – 130.0 million (from $100.0 – 110.0 million) Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consuma

    11/5/25 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

    Compass management will host a conference call at 8:00 am ET (1:00 pm UK) Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 4, 2025. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/698442687. The webcast will be archived for 30 days. About Compass Pathways Compass Pathw

    10/28/25 6:30:00 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Turning Point Brands to Host Q3 Conference Call

    Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review 3rd quarter 2025 results. The conference call will be on Wednesday, November 5, 2025 at 8:30 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/investor-rel

    10/22/25 9:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary